Vilanterol is currently available in the United States only in which formulation?
Show answer and explanation
Correct answer: As a fixed-dose inhaled combination
Vilanterol is an ultra-LABA that is exclusively sold in fixed-dose combinations with corticosteroids (like fluticasone) or muscarinic antagonists (like umeclidinium) for the treatment of asthma and COPD.
Keep practicing
More Beta-2 Agonists questions
- Why is the use of non-selective beta-blockers (like Propranolol) contraindicated in patients using Beta-2 agonists for asthma?
- Which Beta-2 agonist is available in an oral form, though it is rarely used due to increased systemic side effects?
- How do Beta-2 agonists affect the release of inflammatory mediators from mast cells?
- Which molecular structure is a common feature of the 'catecholamine' type Beta-agonists that makes them susceptible to COMT degradation?
- Which statement best describes the use of Beta-2 agonists in the management of COPD compared to asthma?
- A patient with stable asthma is prescribed a combination of Budesonide and Formoterol. What is the pharmacological category of Budesonide?